Add a listing
    Add a listing

    Deciduous Therapeutics

      Immunotherapy to remove senescent cells.

    General
    • Headquarters

      San Francisco, California 94107, United States

    • Founders & Team

      Anil Bhushan, Robin Mansukhani

    • Year Founded

      2016

    • Number of employees

      10

    • Company type

      Private company

    • Funding stage

      Seed

    • Total funding ($M)

      5.8

    • Investors

      Y Combinator

    Technical Details
    • Aging Target

      Cellular senescence

    • Product modality

      small molecule drugs, monoclonal antibody

    About

    Deciduous Therapeutics aims to positively impact human health span through the development of novel medicines that activate the endogenous immune mechanism responsible for the elimination of senescent cells.

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In